NCT06346925 - Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions

Adult Patients With Chronic Primary ITPAdult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy

Interventions

DRUG

Herombopag Olamine Tablets

Three Herombopag Olamine Tablets is administered to healthy subjects.

Trial Locations (1)

The Second Hospital of Anhui Medical Uniersity, Hefei

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY